6,082 filings
Page 12 of 100
6-K
GSK
GSK plc
11 May 23
Current Report of Foreign Issuer
5:57pm
6-K
GSK
GSK plc
9 May 23
Director/pdmr Shareholding
11:38am
6-K
GSK
GSK plc
4 May 23
Director/pdmr Shareholding
10:30am
6-K
GSK
GSK plc
3 May 23
Result of Agm
2:44pm
6-K
GSK
GSK plc
3 May 23
Us Fda Approves GSKS RSV Vaccine for Older Adults
2:34pm
6-K
GSK
GSK plc
2 May 23
Total Voting Rights
10:36am
6-K
GSK
GSK plc
28 Apr 23
Director/pdmr Shareholding
12:53pm
6-K
GSK
GSK plc
27 Apr 23
GSK RSV Oa Vaccine Gains Positive Ema CHMP Opinion
6:50am
6-K
GSK
GSK plc
26 Apr 23
1ST Quarter Results
12:01pm
6-K
GSK
GSK plc
25 Apr 23
Ema Validates Jemperli Filing for New Indication
6:34am
6-K
GSK
GSK plc
20 Apr 23
Director/pdmr Shareholding
10:53am
6-K
GSK
GSK plc
19 Apr 23
Director/pdmr Shareholding
11:09am
6-K
GSK
GSK plc
18 Apr 23
GSK Reaches Agreement to Acquire Bellus Health Inc
7:55am
6-K
GSK
GSK plc
17 Apr 23
Director/pdmr Shareholding
10:54am
6-K
GSK
GSK plc
17 Apr 23
Gepotidacin Positive Phase III Data
6:26am
20-F/A
2022 FY
GSK
GSK plc
17 Apr 23
Annual report (foreign) (amended)
12:00am
6-K
GSK
GSK plc
3 Apr 23
Total Voting Rights
8:10am
6-K
GSK
GSK plc
28 Mar 23
Positive Phase III Ruby Results for Jemperli
8:00am
6-K
GSK
GSK plc
27 Mar 23
Publication of 2023 Agm Notice
8:51am
6-K
GSK
GSK plc
24 Mar 23
Statement: Zantac (Ranitidine) Litigation
8:29am